Literature DB >> 18300277

Gastroenterologists' attitudes and self-reported practices regarding inflammatory bowel disease.

Andrea Altschuler1, Bernadette Collins, James D Lewis, Fernando Velayos, James E Allison, Susan Hutfless, Liyan Liu, Lisa J Herrinton.   

Abstract

BACKGROUND: The purpose was to assess organization-, physician-, and patient-based aspects of inflammatory bowel disease (IBD) practice variation within an integrated care delivery system and the extent to which physicians are interested in adopting a chronic care model and/or nurse assistance to manage IBD patients.
METHODS: As part of an observational cohort study to understand variation in IBD care and outcomes, we conducted semistructured, open-ended interviews with 17 gastroenterologists and 1 gastroenterology registered nurse at 6 clinics in an integrated care delivery system. Interviews were taperecorded and transcribed. We coded and analyzed transcripts using standard qualitative methods.
RESULTS: Physicians reported a range of attitudes and practices regarding IBD. Analysis showed differences in 3 domains and 8 subdomains: 1) patient education and choices, including health education and patient use of complementary and alternative medicine; 2) decisions about diagnosis and treatment, including practice guidelines, conferring with colleagues, using infliximab, and medical hospitalization; and 3) organizational aspects of care, including primary care involvement with IBD and MD attitudes toward ancillary support.
CONCLUSIONS: Standardized algorithms on care for IBD patients do not exist, but opportunities may exist to improve IBD care by: having initial work-ups and management of patients in remission in primary care; creating and maintaining opportunities for gastroenterologists to confer with colleagues and acknowledged local experts; and having nurse coordination for medications and labs and/or some type of specialty IBD clinic for high-need patients. This research highlights the need for more directed comparative efficacy and effectiveness trials that will serve to define preferred treatment strategies.

Entities:  

Mesh:

Year:  2008        PMID: 18300277     DOI: 10.1002/ibd.20416

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  13 in total

Review 1.  Quality of care delivered to hospitalized inflammatory bowel disease patients.

Authors:  Adam V Weizman; Geoffrey C Nguyen
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

2.  Timing of myelosuppression during thiopurine therapy for inflammatory bowel disease: implications for monitoring recommendations.

Authors:  James D Lewis; Oren Abramson; Monina Pascua; Liyan Liu; Laura M Asakura; Fernando S Velayos; Susan M Hutfless; James E Alison; Lisa J Herrinton
Journal:  Clin Gastroenterol Hepatol       Date:  2009-07-22       Impact factor: 11.382

Review 3.  Quality of health care in the United States: implications for pediatric inflammatory bowel disease.

Authors:  Brendan M Boyle; Lena Palmer; Michael D Kappelman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-09       Impact factor: 2.839

Review 4.  Quality Improvement Initiatives in Inflammatory Bowel Disease.

Authors:  Sameer K Berry; Corey A Siegel; Gil Y Melmed
Journal:  Curr Gastroenterol Rep       Date:  2017-08

Review 5.  Implementing quality measures for inflammatory bowel disease.

Authors:  Shahzad Ahmed; Corey A Siegel; Gil Y Melmed
Journal:  Curr Gastroenterol Rep       Date:  2015-04

6.  State of Adult Trainee Inflammatory Bowel Disease Education in the United States: A National Survey.

Authors:  Benjamin L Cohen; Christina Ha; Ashwin N Ananthakrishnan; Florian Rieder; Meenakshi Bewtra
Journal:  Inflamm Bowel Dis       Date:  2016-07       Impact factor: 5.325

7.  Perceived Emotional and Psychological Impact of Ulcerative Colitis on Outpatients in Spain: UC-LIFE Survey.

Authors:  Antonio López-Sanromán; Daniel Carpio; Xavier Calvet; Cristina Romero; Luis Cea-Calvo; Berta Juliá; Federico Argüelles-Arias
Journal:  Dig Dis Sci       Date:  2016-11-05       Impact factor: 3.199

Review 8.  Interventions and targets aimed at improving quality in inflammatory bowel disease ambulatory care.

Authors:  Adam V Weizman; Geoffrey C Nguyen
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

9.  Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy.

Authors:  Zaid Bilgrami; Ameer Abutaleb; Kenechukwu Chudy-Onwugaje; Patricia Langenberg; Miguel Regueiro; David A Schwartz; J Kathleen Tracy; Leyla Ghazi; Seema A Patil; Sandra M Quezada; Katharine M Russman; Charlene C Quinn; Guruprasad Jambaulikar; Dawn B Beaulieu; Sara Horst; Raymond K Cross
Journal:  Dig Dis Sci       Date:  2019-01-02       Impact factor: 3.199

10.  Quality improvement in inflammatory bowel disease.

Authors:  Gil Y Melmed; Corey A Siegel
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.